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Pharmacy use by dual-eligible non-elderly
veterans with private healthcare insurance
Brian C. Lund1,2*, Mary E. Charlton1,2 and Alan N. West3,4
Abstract
Background: Utilization of private sector healthcare services among dual enrolled veterans with private healthcare
insurance plans (PHIP) has not been well-characterized. Concurrent use of Veterans Health Administration (VHA) and
non-VHA pharmacies may increase risk for adverse outcomes. Thus, the objectives of this study were to determine
the extent to which dual VHA-PHIP enrollees obtain medications through VHA and non-VHA pharmacies and to
characterize medications obtained through non-VHA pharmacies.
Methods: This observational study used merged administrative data from VHA and a predominant regional PHIP to
select veterans < 65 years of age, residing in two Midwestern US states, and simultaneously enrolled in both VHA
and the PHIP during fiscal years (FY) 2001–2010. Primary outcome measures included counts of prescriptions
dispensed from VHA and non-VHA pharmacies, and frequencies of medications dispensed by non-VHA pharmacies
based on PHIP claims.
Results: Of 5783 veterans who filled ≥ 1 prescription in FY10, 2935 (50.8 %) used non-VHA pharmacies exclusively,
1165 (20.2 %) used VHA pharmacies exclusively and 1683 (29.1 %) were dual users. Health services utilization was
higher for dual users compared to exclusive users of either VHA or non-VHA pharmacies across multiple measures,
including total prescriptions, outpatient encounters, and inpatient admissions. The most common medications
dispensed by non-VHA pharmacies, by proportion of veterans treated, were hydrocodone (20.9 %), amoxicillin (18.
5 %), simvastatin (17.5 %), azithromycin (17.4 %), and lisinopril (15.1 %). Antidepressants comprised 3 of 10 most
common medications dispensed by VHA, but none of the most common medications dispensed to exclusive
non-VHA pharmacy users.
Conclusions: Our findings align with VHA-Medicare dual enrolled veterans where only a minority of veterans used
VHA services exclusively. Younger veterans relied disproportionately on VHA for mental health medications.
Keywords: Access to care, Veterans, Drugs, Health insurance
Background
The Veterans Health Administration (VHA) is the lar-
gest nationally integrated healthcare system in the
United States, operating 168 medical centers and more
than 1000 community based outpatient clinics. However,
many veterans seek care outside the VHA system, par-
ticularly when they are also covered by state or federal
programs such as Medicare or Medicaid, or have access
to private health insurance, often through employment.
Concerted efforts have been made to facilitate commu-
nication and coordinate care between VHA and private
sector healthcare, but concurrent use of these systems
adds to an already fragmented U.S health care system.
The use of private sector healthcare services by veterans
dual enrolled in Medicare and VHA has been well char-
acterized in older adults [1–4]. Of dual enrolled elderly
veterans who used outpatient healthcare services in
1999, 18 % were VHA only users, 36 % were Medicare
only users, and the remaining 46 % were dual users of
both VHA and private sector services [1]. A more recent
report examining both inpatient and outpatient services
during 2004–2009 for veterans dual enrolled in a
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Medicare Advantage plan found that 10 % of patients
used VHA exclusively, 35 % used the Medicare plan ex-
clusively, 50 % used both systems, and the remaining
4 % did not use services in either system [4]. In addition
to potential inefficiencies and unnecessary duplication of
services [4], a chief concern is that dual use may in-
crease risk for adverse events arising from lack of coord-
ination between systems, though studies supporting this
hypothesis are inconclusive [5, 6].
While on-going examination of VHA-Medicare dual
use in older adult veterans is warranted, virtually no data
exist regarding younger veterans enrolled in a private
health insurance plan (PHIP). The influx of younger vet-
erans returning from service in Operation Enduring/
Iraqi Freedom (OEF/OIF) makes this issue increasingly
relevant, as most of these individuals will qualify for
VHA enrollment, and many will concurrently have ac-
cess to a PHIP through employment or purchased
through Affordable Care Act exchanges. A large survey
of veterans conducted in 1999 found that 32.7 % of
VHA enrollees less than 65 years of age had private in-
surance without Medicare [3]. Of these, 16.8 % were
VHA only users, 35.0 % used non-VHA services exclu-
sively, 39.9 % were dual users, and the remaining 8.3 %
used no services. Unfortunately, more recent data are
unavailable and a more detailed characterization of the
type of services used is also lacking. For example, in
the Medicare aged population, the proportion of
VHA patients who used Medicare-reimbursed services
was approximately 30 % for primary care, exceeded
60 % for specialty services, but was only 3–4 % for
mental health care [2].
One such service domain of particular salience is dual
pharmacy use across systems, where lack of appropriate
care coordination could lead to dangerous drug-drug in-
teractions, as well as unnecessary duplication or gaps in
therapeutic monitoring. One survey conducted among
veterans age ≥ 65 years and engaged in care at a single
VHA site in 2008 found that 44.3 % used only VHA
pharmacies, and the remaining 55.7 % had some degree
of non-VHA pharmacy use [7]. In this sample, 21.2 % of
veterans had medication coverage through Medicare
Part D, and a further 39.7 % of veterans had private in-
surance not obtained through Medicare Part D. Unsur-
prisingly, veterans with non-VHA drug benefits were
significantly more likely to use non-VHA pharmacies.
However, 43.8 % of veterans without any form of non-
VHA drug coverage still reported some pharmacy use
outside the VHA system. Unfortunately, no data are
available concerning dual pharmacy use among younger
veterans, pharmacy use among VHA enrolled veterans
engaged exclusively in non-VHA care, or specific infor-
mation about the most commonly filled medications
outside VHA by dual users.
In order to address some of these important know-
ledge gaps, we acquired claims data from a predominant
regional PHIP to combine service utilization data across
both systems. Our study is the first to focus on pre-
Medicare age veterans and examine how dually enrolled
VHA-PHIP beneficiaries use VHA and non-VHA ser-
vices. The specific objectives of this report are to deter-
mine the extent to which dual enrollees < 65 years
obtain medications through VHA and non-VHA phar-
macies, contrast patient characteristics among primary
VHA pharmacy users, non-VHA pharmacy users, and
dual users, and to characterize the most common medi-
cations obtained through non-VHA pharmacies.
Methods
Study population and cohort creation
Patients included all veterans under age 65 who resided
in two Midwestern states and were simultaneously en-
rolled in both VHA and our partnered PHIP for at least
one full fiscal year between October 1, 2000 and
September 30, 2010. The current analysis focused on
veterans who were dual enrolled during the most recent
year (FY10). We also conducted some analyses among
dual enrollees during FY02, the earliest year where phar-
macy refill data was available, to examine potential
changes in dual system pharmacy use over the study
timeframe. The PHIP agreement stipulated that we
could only link their claim-level data to aggregated,
patient-level VHA data. Therefore, summary variables of
VHA utilization were extracted by Veterans Affairs (VA)
National Data Systems (NDS) for each fiscal year of en-
rollment and linked to person-level PHIP membership
data extract. VHA summary variables included annual
counts of: 1) inpatient medical admissions, 2) outpatient
medical visits, 3) inpatient mental health admissions, 4)
outpatient mental health visits, and 5) dispensed pre-
scription medications. These variables were derived from
the Medical SAS Outpatient Data and the Acute Care
Medical SAS Inpatient Data constructed from the
National Patient Care Database (NPCD), and the Deci-
sion Support System (DSS) Pharmacy Data. Comparable
summary variables were created at the patient-level
using claim-level PHIP data to measure private sector
service utilization. Since VHA can bill PHIPs for services
provided to veterans for non-service connected condi-
tions, we identified all PHIP claims originating from
VHA facilities based on their federal tax identification
numbers, and these events were omitted from the PHIP
utilization variables. Service connection is a proportion
ranging from 0 to 100 % that is assigned by the U.S.
Department of Affairs to individual veterans though a
benefits review process and denotes the extent to which
a veteran’s injury or disease is linked to their military ser-
vice. Veterans with greater levels of service connection
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generally have lower out-of-pocket costs, such as reduced
or eliminated copays for medications, which may impact
their decision whether to use VHA versus non-VHA care.
Pharmacy utilization
Patients were classified into pharmacy user status
groups: exclusive VHA users, exclusive non-VHA users,
or dual users. Individual prescription medications dis-
pensed by non-VHA pharmacies were identified in PHIP
claims using a text field containing the drug name.
Medication frequencies included all single agent and
combination products that contained that ingredient,
identified using both brand and generic drug names. For
example, the frequency of lisinopril use included all sin-
gle agent drug products and combination products (e.g.
lisinopril/hydrochlorothiazide combination products) and
included all brand name versions of these products.
Common VHA medications
Since we were restricted to patient-level aggregate VHA
data, we could not identify individual medications dis-
pensed by VHA to patients in our cohort. In order to
provide a point of reference for interpreting the frequen-
cies of common medications dispensed by non-VHA
pharmacies, we created a proxy using the most common
prescription medications dispensed to all VHA patients
age 18–64 years receiving care at the 4 VHA medical
centers with geographic boundaries overlapping the
PHIP coverage area. These analyses used prescription
data from the VA Decision Support System National
Data Extract SAS Pharmacy datasets.
Analysis
Differences in patient characteristics and health service
utilization variables were compared across patient
groups using chi-squared tests for categorical variables
and analysis of variance for discrete variables. The
equivalent nonparametric Wilcoxon rank sum test was
substituted for variables that were not normally distrib-
uted. All statistical tests were conducted using SAS ver-
sion 9.3 (Cary, NC) and were two-sided with a
significance threshold of α = .05.
Results
In FY02, 4022 non-elderly veterans were simultaneously
enrolled in both VHA and the PHIP, which increased to
7087 veterans in FY10. Of the FY02 cohort, 1117
(27.8 %) patients were also dual enrolled in FY10. The
mean age of dual eligible veterans increased from 51.2 to
52.4 years during this time period (Table 1). The distri-
bution of age was highly skewed, where only 8.3 % of pa-
tients were < 35 years in FY02, and 40.8 % were 55–64
years. The over 55 age group increased to nearly 60 % of
the sample by FY10. The majority of patients were male,
though the proportion of women grew from 3.6 to 5.6 %
during the observation period. The proportion of rural
veterans decreased from 67.2 to 59.5 %.
Of the 7087 dual enrolled veterans in FY10, 5783
(81.6 %) filled at least one prescription. Of these, approxi-
mately half (N = 2935, 50.8 %) used non-VHA pharmacies
exclusively, 20.2 % (N = 1165) used VHA pharmacies ex-
clusively, and the remaining 29.1 % (N = 1683) had some
degree of dual use between VHA and non-VHA pharma-
cies (Fig. 1). This distribution remained stable across indi-
vidual years from FY02 through FY10, where the
proportion of VHA only users varied from 18.6 to 22.1 %
and non-VHA only users varied from 48.4 to 51.9 %.
Demographic characteristics and health service utilization
were contrasted across FY10 pharmacy user status groups
(Table 2). The proportion of women was highest among
non-VHA only users (6.9 %) and lowest among VHA only
users (3.4 %). The proportion of rural veterans was highest
among dual users (64.2 %), compared to rates of 58.3 and
60.7 % for exclusive non-VHA and exclusive VHA users,
respectively. The level of service connection was similar
Table 1 Patient characteristics
Characteristic FY 2002 FY 2010 Statistics
N = 4022 N = 7087 X2 or Z; DF; p
Age in years, mean (S.D.) 51.2 (9.2) 52.4 (11.0) Za = 15.0; <.001
Age group, n (%) X2 = 362; 3; <.001
< 35 years 335 (8.3) 716 (10.1)
35–44 years 490 (12.2) 963 (13.6)
45–54 years 1556 (38.7) 1218 (17.2)
55–64 years 1641 (40.8) 4190 (59.1)
Sex, n (%) X2 = 22.4; 1; <.001
Male 3879 (96.4) 6693 (94.4)
Female 143 (3.6) 394 (5.6)
Marital Status, n (%) X2 = 48.6; 3; <.001
Married 1295 (32.2) 2677 (37.8)
Never Married 144 (3.6) 294 (4.2)
Divorced or Widowed 2323 (57.8) 3609 (50.9)
Unknown 260 (6.5) 507 (7.2)
Residence, n (%) X2 = 60.8; 1; <.001
Urban 1308 (32.5) 2819 (39.8)
Rural 2702 (67.2) 4214 (59.5)
Unknown 12 (0.3) 54 (0.8)
Service Connection, n (%) X2 = 32.6; 4; <.001
None 2439 (60.6) 4408 (62.2)
1–10 % 568 (14.1) 1079 (15.2)
11–80 % 837 (20.8) 1397 (19.7)
81–100 % 54 (1.3) 92 (1.3)
Unknown 124 (3.1) 111 (1.6)
aWilcoxon rank sum test, normal approximation, two-sided test
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Fig. 1 Proportion of Prescriptions Filled by Non-VHA Pharmacies in Non-Elderly, Dual-Eligible Veterans, 2010 (N = 5783)
Table 2 Clinical characteristics of patients according to pharmacy user status, 2010
Pharmacy user status group (N = 5783)
Characteristic VHA only Dual Non-VHA only Statistics
N = 1165 N = 1683 N = 2935 X2 or F; DF; p
Age, mean (SD) 53.7 (10.2) 54.9 (9.7) 52.5 (10.8) F = 29.2; DF = 2; p < .001
Sex, n (%)
Male 1125 (96.6) 1590 (94.5) 2732 (93.1) X2 = 18.8; DF = 2; p < .001
Female 40 (3.4) 93 (5.5) 203 (6.9)
Residence, n (%)
Rural 707 (60.7) 1080 (64.2) 1712 (58.3) X2 = 15.7; DF = 4; p = .003
Urban 449 (38.5) 593 (35.2) 1197 (40.8)
Unknown 9 (0.8) 10 (0.6) 26 (0.9)
Service Connection, n (%)
None 585 (50.2) 852 (50.6) 2070 (70.5) X2 = 447; DF = 8; p < .001
1–10 % 185 (15.9) 255 (15.2) 449 (15.3)
11–80 % 369 (31.7) 523 (31.1) 331 (11.3)
81–100 % 20 (1.7) 49 (2.9) 19 (0.7)
Unknown 6 (0.5) 4 (0.2) 66 (2.3)
Prescription fills, mean (SD) 17.6 (17.2) 31.7 (25.5) 21.7 (21.7) F = 164; DF = 2; p < .001
Outpatient visits, mean (SD)
Medical 14.3 (13.5) 23.6 (21.9) 13.6 (16.3) F = 183; DF = 2; p < .001
Mental health 1.4 (4.1) 1.8 (5.5) 0.7 (5.6) F = 26.9; DF = 2; p < .001
Total 15.7 (14.8) 25.4 (23.5) 14.2 (17.5) F = 191; DF = 2; p < .001
Inpatient admission, n (%)
Medical 46 (4.0) 177 (10.5) 214 (7.3) X2 = 43.1; DF = 2; p < .001
Mental health 5 (0.4) 16 (1.0) 5 (0.2) X2 = 14.6; DF = 2; p < .001
Any 50 (4.3) 191 (11.4) 219 (7.5) X2 = 48.8; DF = 2; p < .001
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between VHA only and dual users, but significantly lower
among non-VHA only pharmacy users. Overall health ser-
vice utilization, which included both non-VHA care reim-
bursed by the PHIP and VHA care, was highest among
dual users, including the number prescription fills, number
of outpatient visits, and the proportion of patients who had
an inpatient hospitalization. Dual users also had the highest
mean number of outpatient mental health visits and the
greatest proportion of patients with an inpatient mental
health admission.
The medications most frequently dispensed by non-
VHA pharmacies to dual enrolled veterans are listed in
Table 3. Hydrocodone (with or without combined acet-
aminophen) was the most commonly filled medication
and dispensed to 963 (20.9 %) unique patients. Five of
the most common medications were antibiotics, includ-
ing amoxicillin and azithromycin in the top 5, followed
by cephalexin, ciprofloxacin, and levofloxacin. Several
chronic medications for cardiovascular-related diseases
were also present, including simvastatin and lisinopril in
the top 5, as well as metoprolol, hydrochlorothiazide,
metformin, and atorvastatin. The frequency of these
non-VHA dispensed medications was further contrasted
between dual pharmacy users and exclusive non-VHA
pharmacy users. The consistent trend across medications
was that frequencies for medications commonly taken
on an acute basis did not differ between groups, whereas
the frequency of chronic medications was significantly
lower among dual users. For example, hydrocodone was
dispensed to 963 (20.9 %) dual users and to 616 (21.0 %)
non-VHA only users, which was not significantly differ-
ent (X2 = .09; DF = 1; p = .766). In contrast, simvastatin
was dispensed by non-VHA pharmacies to 180 (10.7 %)
dual users versus 629 (21.4 %) non-VHA only users
(X2 = 85; DF = 1; p < .001).
The frequency of the most common medications dis-
pensed by VHA (i.e. the 4 VHA medical centers with geo-
graphic boundaries that overlapped the PHIP coverage
areas) was contrasted with the most common medications
dispensed to dual enrolled veterans who used non-VHA
pharmacies exclusively (Table 4). Use of common chronic
medications including lisinopril, metoprolol, metformin,
and hydrochlorothiazide, was generally consistent between
VHA patients and non-VHA pharmacy users in the older
age group (45–64 years). Simvastatin use was more com-
mon in VHA, but comparable to the combined use of sim-
vastatin plus atorvastatin use in the dual enrolled,
non-VHA pharmacy user group. In contrast, important dif-
ferences were observed in the younger age group (18–44
years), particularly related to psychotropic medication. The
10 most frequent medications in VHA included two
antidepressants (citalopram and bupropion), one hyp-
notic (zolpidem), and one antidepressant used almost
exclusively as a hypnotic (trazodone). No antidepres-
sants appeared in the top 10 medications for the
non-VHA pharmacy group.














Hydrocodone 963 (20.9) 347 (20.6) 616 (21.0) .09; 1; .766
Amoxicillin 853 (18.5) 338 (20.1) 515 (17.6) 4.6; 1; .033
Simvastatin 809 (17.5) 180 (10.7) 629 (21.4) 85; 1; <.001b
Azithromycin 802 (17.4) 304 (18.1) 498 (17.0) .89; 1; .344
Lisinopril 699 (15.1) 185 (11.0) 514 (17.5) 35; 1; <.001b
Omeprazole/esomeprazole 477 (10.3) 127 (7.6) 350 (11.9) 22; 1; <.001b
Prednisone 429 (9.3) 173 (10.3) 256 (8.7) 3.1; 1; .079
Cephalexin 422 (9.1) 172 (10.2) 250 (8.5) 3.7; 1; .053
Metoprolol 391 (8.5) 105 (6.2) 286 (9.7) 17; 1; <.001b
Hydrochlorothiazide 374 (8.1) 92 (5.5) 282 (9.6) 25; 1; <.001b
Metformin 338 (7.3) 82 (4.9) 256 (8.7) 23; 1; <.001b
Ciprofloxacin 313 (6.8) 129 (7.7) 184 (6.3) 3.3; 1; .069
Levofloxacin 292 (6.3) 118 (7.0) 174 (5.9) 2.1; 1; .146
Cyclobenzaprine 289 (6.3) 88 (5.2) 201 (6.9) 4.8; 1; .029
Atorvastatin 243 (5.3) 41 (2.4) 202 (6.9) 42; 1; <.001b
aIncludes all single agent and combination products that contain the ingredient medication (e.g. lisinopril includes combination formulations with other active
ingredients such as hydrochlorothiazide; amoxicillin includes amoxicillin plus clavulanate combination products). Cell counts represent the number of unique
patients who received each medication during FY10
bStatistically significant difference based on Bonferroni correction for multiple comparisons (α = 0.0033)
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Discussion
Our primary objective was to determine the extent to
which younger, dual VHA-PHIP enrolled veterans ob-
tained medications from VHA versus non-VHA pharma-
cies. We found that in FY10, approximately half (50.8 %)
used non-VHA pharmacies exclusively, only 20.2 % used
VHA pharmacies exclusively, and the remaining 29 %
used both. This finding is similar to older, VHA-
Medicare dual enrolled veterans, where 20 % or less of
this population used VHA services exclusively [1, 4].
However, exclusive non-VHA pharmacy use was more
common in our sample of younger PHIP enrolled vet-
erans (50.8 %), compared to approximately 35 % in pre-
vious reports involving the older, Medicare enrolled
veteran population [1, 4]. While the number of dual en-
rolled veterans increased, the distribution of VHA versus
PHIP use was stable over the span of our observation
period, which extended from FY02 to FY10. While not a
focus of the current research, we hypothesize that the
increase in dual enrollees resulted from increasing num-
bers of working age veterans enrolling in VA over the
study period, and that use of VA health care has in-
creased across all ages since 2005. Furthermore, the pro-
portion of veterans under 35 years of age who are VA
patients increased 3-fold during this period [8]. This
growth has been attributed to increased outreach efforts
by the VA, expanding lists of conditions that qualify for
VA coverage, and a streamlined enrollment process [8].
Several differences in patient characteristics were ob-
served across pharmacy user groups. Compared to the
other two groups, exclusive non-VHA pharmacy users
were disproportionately women and had lower rates of
service connection. Dual users differed from both VHA
and non-VHA exclusive users in having a higher propor-
tion of rural residents and greater total service
utilization across all domains, including inpatient hospi-
talizations, outpatient visits, and prescription fills. These
patterns are generally consistent with previous reports
involving dual VHA-Medicare users [1, 3, 9, 10]. VHA
has made strides to address many of these issues, par-
ticularly in expanding women’s health services to meet
the growing population of women veterans and in
Table 4 Most common medications dispensed in VHA contrasted with dual enrolled exclusive non-VHA pharmacy users, 2010
Age group: 18–44 years
VHA systema N = 10,371
n (%)




Es/omeprazole 1792 (17.3) Hydrocodone 150 (21.6)
Hydrocodone 1766 (17.0) Amoxicillin 140 (20.2)
Citalopram 1554 (15.0) Azithromycin 134 (19.3)
Ibuprofen 1292 (12.5) Prednisone 73 (10.5)
Simvastatin 1246 (12.0) Cyclobenzaprine 72 (10.4)
Bupropion 1165 (11.2) Cephalexin 55 (7.9)
Trazodone 1087 (10.5) Es/omeprazole 44 (6.3)
Tramadol 1008 (9.7) Simvastatin 42 (6.1)
Zolpidem 988 (9.5) Lisinopril 40 (5.8)
Naproxen 952 (9.2) Zolpidem 39 (5.6)
Age group: 45–64 years
VHA systema N = 37,795
n (%)




Simvastatin 14,861 (39.2) Simvastatin 587 (26.2)
Es/omeprazole 10,251 (27.0) Lisinopril 474 (21.2)
Lisinopril 11,335 (29.9) Hydrocodone 466 (20.8)
Hydrocodone 6960 (18.3) Amoxicillin 375 (16.7)
Metoprolol 6048 (15.9) Azithromycin 364 (16.2)
Vardenafil 5673 (15.0) Es/omeprazole 306 (13.7)
Metformin 5670 (14.9) Metoprolol 278 (12.4)
Hydrochlorothiazide 5519 (14.5) Hydrochlorothiazide 267 (11.9)
Amlodipine 4348 (11.5) Metformin 243 (10.8)
Albuterol inhaler 3615 (9.5) Atorvastatin 196 (8.8)
aThe VHA system included all patients receiving care at the 4 VHA medical centers with geographic borders that overlapped with the coverage area of the private
health insurance plan. Cell counts represent the number of unique patients who received each medication during FY10
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creating the VA Office of Rural Health in 2007 to ex-
pand access for rural veterans using telehealth and other
innovative approaches to healthcare delivery. Future
studies will be needed to determine the success of these
initiatives in ensuring that all eligible veterans who want
to receive their healthcare from VHA are able to access
these services.
Our analysis further examined the specific medications
most commonly dispensed to dual VHA-PHIP enrolled
veterans in non-VHA pharmacies. The most common
medications included treatments for both chronic dis-
eases such as hyperlipidemia (simvastatin, atorvastatin),
diabetes (metformin), and hypertension (lisinopril, meto-
prolol, hydrochlorothiazide), as well as acute indications
such as infectious diseases (amoxicillin, azithromycin,
cephalexin, ciprofloxacin, levofloxacin) and pain (hydro-
codone). Among medications dispensed by non-VHA
pharmacies, dual users and exclusive non-VHA phar-
macy users had similar rates for acute medications, but
dual users had significantly lower rates for chronic medi-
cations. This pattern suggests that both patient groups
seek care outside VHA for acute conditions such as pain
or infection at approximately equal rates. In contrast,
dual users may be less likely to have chronic medications
filled by non-VHA pharmacies because they are being
filled and managed within VHA. Unfortunately, we
could not test this assumption directly because we did
not know which specific drugs were dispensed by VHA
pharmacies, only the total number of prescriptions dis-
pensed. Despite this important limitation, our findings
suggest that dual users seek care across systems in a ra-
tional manner, selectively using VHA for the manage-
ment of chronic disease states, but preferring more
accessible non-VHA services for acute conditions.
In order to indirectly address the lack of drug specific
information for prescriptions dispensed by VHA phar-
macies to patients in our sample, we identified the most
common medications dispensed to all veterans across
the four VHA facilities that overlapped geographically
with the PHIP catchment area as a proxy. The drugs
most commonly prescribed to PHIP enrolled veterans
who were exclusive users of non-VHA pharmacies was
very similar to the VHA system as a whole for patients
in the 45–64 year age range. Rates of use were nearly
identical between systems for medications used to treat
chronic diseases, including statins (simvastatin and ator-
vastatin), lisinopril, metoprolol, and others. These pat-
terns suggest not only similar frequencies of common
chronic diseases between VHA users and non-users in
this age range, but also very similar provider choices re-
garding specific medications. However, prescribing pat-
terns were substantially different for patients under
45 years. The antidepressants citalopram (15.0 %) and
bupropion (11.2 %) were among the most common
drugs in this age group in VHA. The antidepressant
trazodone was also common (10.5 %), though this medi-
cation is used almost exclusively for insomnia. In con-
trast, the most common drugs dispensed to non-VHA
pharmacy users did not include any antidepressants.
This discrepancy has several potential explanations.
First, prior reports have documented that veterans se-
lectively seek mental health services from VHA [2]. This
may be partly explained by individuals with major men-
tal disorders having less access to employer-based
PHIPs, or fewer mental health benefits offered by their
PHIP than available through VHA. Alternatively, it is
possible that PHIP patients more often choose non-drug
treatments such as psychotherapy. Finally, rates of men-
tal disorders may be similar across settings but the pri-
vate sector is less adept than VHA in recognizing and
screening their veteran patients for posttraumatic stress
disorder, depression, suicidal ideation, and other related
mental health issues.
This study is subject to several important limitations.
First, we only had a count of prescriptions dispensed by
VHA to our dual enrolled PHIP veterans but did not
know specifically which medications were dispensed. We
were thus unable to examine some important questions
regarding dual VHA-PHIP pharmacy use, such as
whether unsafe or duplicative medications were dis-
pensed across systems to an individual patient. A further
limitation was that we could only examine dual use in
one regional Midwest PHIP. We did not have access to
data from other PHIPs in the same region or informa-
tion about out-of-pocket pharmacy purchases, and thus
the actual rate of exclusive VHA pharmacy use may be
even lower than our estimate of 20.2 %. Importantly, our
PHIP accounts for 50–75 % of market share across the
two states included in our study. We also do not know
whether our findings can be generalized to other regions
of the country, where factors such as regional differences
in available PHIP benefits and VHA access could impact
how dual enrolled veterans selectively use VHA versus
non-VHA services. It is also unclear what impact recent
legislation, such as the Affordable Care Act and the
Veterans Access, Choice, and Accountability Act, may have
on how dual enrolled patients seek services across systems.
Conclusions
Our findings have important implications for various
stakeholders. It is critical for national healthcare policy
to understand how patients selectively interact with
VHA and the private sector as beneficiaries of Medicare,
Medicaid, PHIPs, and other payers. The consistency of
our findings with prior studies of Medicare dual users
suggests that patterns of dual use may be well-
established prior to reaching Medicare eligibility. It is
likely that PHIP enrolled veterans selectively use private
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sector services and then maintain this pattern as they
transition to Medicare. Policy-makers and organizations
specifically concerned with ensuring healthcare access
among individuals with mental health disorders should
recognize the key role that VHA plays for veterans with
these illnesses. Our findings are relevant to VHA clini-
cians who face co-management across VHA and the pri-
vate sector, and specifically with knowing common
drugs their patients may be receiving from non-VHA
sources and not necessarily well-documented in the
VHA medical record. Our findings should also be of
interest to investigators conducting research using VHA
administrative data to understand what drug exposures
are most likely to be missing from VHA data in pre-
Medicare aged veterans and the potential impact on
their findings. For example, studies concerned with iden-
tifying outpatient medication use for acute conditions
such as pain or infection may be substantially biased
since dual enrolled PHIP users frequently get these med-
ications filled outside VHA. Our findings highlight the
need for further research examining the potential risks,
as well as potential benefits, of dual VHA and private
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